SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing presentation: reset
Immune-Mediated Viral Control With Budigalimab ± Trosunilimab: First Results of Phase II Global RCT
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
Immune-Mediated Viral Control With Budigalimab ± Trosunilimab: First Results of Phase II Global RCT (ABSTRACT
140)
Ana Gabriela Pires Dos Santos
AbbVie, Inc, North Chicago, IL, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
